Company Revenue

The company grew 63% on a reported basis in the third quarter of 2024 as it anniversaried its merger with...

The company's orthopedic sales grew in the mid-single digits but headwinds in China will have an ongoing impact into 2025....

The company declined in the mid-single digits during the third quarter of 2024 as it pivots away from Arthrosurface and...

The company grew more than 27% in the third quarter of 2024 as it hones its focus on attaining cash...

The company grew in the mid-single digits in the third quarter of 2024 as it worked through ERP-related issues impacting...

The company's orthopedic sales grew nearly 5% in the third quarter of 2024 but hurricane impacts will impact fourth quarter...

The company's orthopedic sales grew in the double digits during the third quarter of 2024 amid robust volume and demand....

The company grew over 50% in the third quarter of 2024, driven by continued U.S. market penetration and hospital approvals....

The company's orthopedic sales grew in the low single digits in the third quarter of 2024 on restructuring and APAC...

The company drove mid-single-digit sales growth in the first quarter of its 2025 fiscal year driven by pull through from...